Captor Therapeutics Spolka Akcyjna (WSE:CTX)

WSE:CTX Statistics

Total Valuation

WSE:CTX has a market cap or net worth of PLN 202.35 million. The enterprise value is 145.62 million.

Market Cap	202.35M
Enterprise Value	145.62M

Important Dates

The last earnings date was Friday, September 5, 2025.

Earnings Date	Sep 5, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:CTX has 5.53 million shares outstanding. The number of shares has increased by 2.46% in one year.

Current Share Class	5.53M
Shares Outstanding	5.53M
Shares Change (YoY)	+2.46%
Shares Change (QoQ)	+18.11%
Owned by Insiders (%)	30.99%
Owned by Institutions (%)	32.09%
Float	3.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.53
PB Ratio	3.74
P/TBV Ratio	3.76
P/FCF Ratio	217.82
P/OCF Ratio	140.91
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.67
EV / Sales	10.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	156.75

Financial Position

The company has a current ratio of 3.78, with a Debt / Equity ratio of 0.09.

Current Ratio	3.78
Quick Ratio	3.78
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	5.05
Interest Coverage	-92.93

Financial Efficiency

Return on equity (ROE) is -69.74% and return on invested capital (ROIC) is -41.14%.

Return on Equity (ROE)	-69.74%
Return on Assets (ROA)	-31.70%
Return on Invested Capital (ROIC)	-41.14%
Return on Capital Employed (ROCE)	-70.56%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	91
Asset Turnover	0.18
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.67% in the last 52 weeks. The beta is 0.74, so WSE:CTX's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-53.67%
50-Day Moving Average	40.18
200-Day Moving Average	40.88
Relative Strength Index (RSI)	40.01
Average Volume (20 Days)	4,938

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:CTX had revenue of PLN 13.93 million and -39.71 million in losses. Loss per share was -8.15.

Revenue	13.93M
Gross Profit	9.34M
Operating Income	-39.96M
Pretax Income	-39.71M
Net Income	-39.71M
EBITDA	-34.80M
EBIT	-39.96M
Loss Per Share	-8.15

Balance Sheet

The company has 61.42 million in cash and 4.69 million in debt, giving a net cash position of 56.73 million or 10.26 per share.

Cash & Cash Equivalents	61.42M
Total Debt	4.69M
Net Cash	56.73M
Net Cash Per Share	10.26
Equity (Book Value)	54.14M
Book Value Per Share	9.85
Working Capital	48.46M

Cash Flow

In the last 12 months, operating cash flow was 1.44 million and capital expenditures -507,000, giving a free cash flow of 929,000.

Operating Cash Flow	1.44M
Capital Expenditures	-507,000
Free Cash Flow	929,000
FCF Per Share	0.17

Margins

Gross margin is 67.10%, with operating and profit margins of -286.95% and -285.11%.

Gross Margin	67.10%
Operating Margin	-286.95%
Pretax Margin	-285.11%
Profit Margin	-285.11%
EBITDA Margin	-249.86%
EBIT Margin	-286.95%
FCF Margin	6.67%

Dividends & Yields

WSE:CTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.46%
Shareholder Yield	n/a
Earnings Yield	-19.62%
FCF Yield	0.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

WSE:CTX has an Altman Z-Score of 4.26 and a Piotroski F-Score of 5.

Altman Z-Score	4.26
Piotroski F-Score	5